These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. The impact of tumor stage on prognosis in children with adrenocortical carcinoma. Tucci S; Martins AC; Suaid HJ; Cologna AJ; Reis RB J Urol; 2005 Dec; 174(6):2338-42, discussion 2342. PubMed ID: 16280838 [TBL] [Abstract][Full Text] [Related]
10. Adrenocortical tumors in children: a report of 12 cases. Federici S; Galli G; Ceccarelli PL; Ferrari M; Cicognani A; Cacciari E; Dòmini R Eur J Pediatr Surg; 1994 Feb; 4(1):21-5. PubMed ID: 8199127 [TBL] [Abstract][Full Text] [Related]
11. Feasibility of breast-conserving surgery for patients with breast carcinoma associated with nipple discharge. Cabioglu N; Krishnamurthy S; Kuerer HM; Hunt KK; Singletary SE; Meric-Bernstam F; Ross MI; Feig BW; Ames FC; Babiera GV Cancer; 2004 Aug; 101(3):508-17. PubMed ID: 15274063 [TBL] [Abstract][Full Text] [Related]
12. Adrenocortical carcinoma. Decker RA; Kuehner ME Am Surg; 1991 Aug; 57(8):502-13. PubMed ID: 1928992 [TBL] [Abstract][Full Text] [Related]
13. Functional adrenal cortical tumors in pediatric patients: a clinicopathologic and immunohistochemical study of a long term follow-up series. Bergadá I; Venara M; Maglio S; Ciaccio M; Diez B; Bergadá C; Chemes H Cancer; 1996 Feb; 77(4):771-7. PubMed ID: 8616771 [TBL] [Abstract][Full Text] [Related]
14. Adrenocortical carcinoma: epidemiology and natural history. Boscaro M; Fallo F; Barzon L; Daniele O; Sonino N Minerva Endocrinol; 1995 Mar; 20(1):89-94. PubMed ID: 7651287 [TBL] [Abstract][Full Text] [Related]
15. A phase II trial of combination chemotherapy and surgical resection for the treatment of metastatic adrenocortical carcinoma: continuous infusion doxorubicin, vincristine, and etoposide with daily mitotane as a P-glycoprotein antagonist. Abraham J; Bakke S; Rutt A; Meadows B; Merino M; Alexander R; Schrump D; Bartlett D; Choyke P; Robey R; Hung E; Steinberg SM; Bates S; Fojo T Cancer; 2002 May; 94(9):2333-43. PubMed ID: 12015757 [TBL] [Abstract][Full Text] [Related]
16. Adrenocortical carcinoma in the United States: treatment utilization and prognostic factors. Bilimoria KY; Shen WT; Elaraj D; Bentrem DJ; Winchester DJ; Kebebew E; Sturgeon C Cancer; 2008 Dec; 113(11):3130-6. PubMed ID: 18973179 [TBL] [Abstract][Full Text] [Related]
17. Expression of excision repair cross complementing group 1 and prognosis in adrenocortical carcinoma patients treated with platinum-based chemotherapy. Ronchi CL; Sbiera S; Kraus L; Wortmann S; Johanssen S; Adam P; Willenberg HS; Hahner S; Allolio B; Fassnacht M Endocr Relat Cancer; 2009 Sep; 16(3):907-18. PubMed ID: 19240185 [TBL] [Abstract][Full Text] [Related]
18. Management of adenoid cystic carcinoma of minor salivary glands. Triantafillidou K; Dimitrakopoulos J; Iordanidis F; Koufogiannis D J Oral Maxillofac Surg; 2006 Jul; 64(7):1114-20. PubMed ID: 16781345 [TBL] [Abstract][Full Text] [Related]
19. Craniopharyngiomas in children and adults: systematic analysis of 121 cases with long-term follow-up. Karavitaki N; Brufani C; Warner JT; Adams CB; Richards P; Ansorge O; Shine B; Turner HE; Wass JA Clin Endocrinol (Oxf); 2005 Apr; 62(4):397-409. PubMed ID: 15807869 [TBL] [Abstract][Full Text] [Related]
20. Malignant mixed Müllerian tumors of the uterus: analysis of patterns of failure, prognostic factors, and treatment outcome. Callister M; Ramondetta LM; Jhingran A; Burke TW; Eifel PJ Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):786-96. PubMed ID: 14967435 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]